Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Will Not Pull Teva And MSN Hetlioz ANDAs, Rejects Vanda Citizen Petitions
Jul 09 2025
•
By
Dean Rudge
No discrepancies were found in the products' BE data, the FDA said.
(Shutterstock)
More from Biosimilars & Generics
More from United States